Reduced vaccine production cost
Biological E, a pharmaceutical company, identifies innovative approaches to reduce the cost of vaccine production.
-
Domain
-
Investment typeVolume guarantee
-
StatusExit
-
Initial investmentPrivate
-
Partnered in2012
-
Investment leadNatalie Revelle
-
HeadquartersIndia
-
Program strategyVaccine Delivery
More about our work
Our focus
Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.
Investment approach
Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.
Our team
We bring depth of experience to every investment, with a proven track record across sectors and scale.